Showing results (161-170 of 261) with videos related to

Sort By:
Pageof 27
Gastroenterology|May 20, 2014
Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in miceJunyan Tao, Diego F Calvisi, Sarangarajan Ranganathan, et al.
Oncotarget|September 15, 2017
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in miceAntonio Cigliano, Chunmei Wang, Maria G Pilo, et al.
Cancer Letters|December 3, 2014
The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinomaElgar S Quabius, Tibor Görögh, Gerrit S Fischer, et al.
Cell Death & Disease|January 20, 2018
Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical modelMingjie Dong, Xianqiong Liu, Katja Evert, et al.
Archives of Gynecology and Obstetrics|November 3, 2019
Benign uterine mass-discrimination from leiomyosarcoma by a preoperative risk score: a multicenter cohort studyGünter Köhler, Marcus Vollmer, Neetika Nath, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 24, 2020
Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse HepatocarcinogenesisHaichuan Wang, Jingxiao Wang, Shanshan Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2024
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of GermanyMarkus Krebs, Florian Haller, Silvia Spörl, et al.
BMC Medicine|January 13, 2026
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patientsAlexander Scheiter, Simon Mellin, Felix Keil, et al.
The American Journal of Pathology|April 14, 2020
The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and HumansShu Zhang, Jie Zhang, Katja Evert, et al.
Ejhaem|July 17, 2026
Glofitamab in Heavily Pretreated Mantle Cell Lymphoma Patients: A Multicenter Real-World Case SeriesNatalia Rotter, Markus Raderer, Agnes List, et al.
Pageof 27